BOONE CAPITAL MANAGEMENT LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001882053

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2025 · 11 positions · Total reported value $233.19M · Top-10 concentration 96.9% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 71.4% · 5 new · 5 cut · 5 exited

Active Share (vs S&P 500): 99.4% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.2% · vs SPY -9.3% · Prev Value $427.54M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +6.8% · vs SPY +4.6% · Latest Value $376.70M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, BOONE CAPITAL MANAGEMENT LLC disclosed 11 equity positions with a combined reported value of $233.19M. The filing implies a focused portfolio: its ten largest positions account for 96.9% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were MDT ($37.38M), MIRM ($32.64M), BMRN ($24.60M). By sector, the heaviest allocations are Health Care 80.5%, Industrials 9.8%. Versus the prior quarter, allocation shifted toward Industrials (+9.8pp) and away from Financials (-9.7pp).

Versus the prior quarter, BOONE CAPITAL MANAGEMENT LLC opened 5 new positions, trimmed 5 and fully exited 5, a turnover rate of 71.4% of positions. The portfolio's overlap with the prior quarter was 35% of names.

The largest new positions opened in Q2 2025 were AVTR ($22.81M), NBIX ($22.67M), UNH ($18.13M).

Of the 5 positions fully exited versus the prior quarter, the largest were GMED ($26.41M), MOH ($22.25M), PRGO ($19.76M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • AVTR AVANTOR INC · $22.81M
  • NBIX NEUROCRINE BIOSCIENCES INC · $22.67M
  • UNH UNITEDHEALTH GROUP INC · $18.13M
  • ICLR ICON PUB LTD CO · $13.94M
  • ABEO ABEONA THERAPEUTICS INC · $7.13M

Fully Exited (vs previous quarter)

  • GMED GLOBUS MED INC · prev qtr: $26.41M
  • MOH MOLINA HEALTHCARE INC · prev qtr: $22.25M
  • PRGO PERRIGO CO PLC · prev qtr: $19.76M
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $19.28M
  • OFIX ORTHOFIX MED INC · prev qtr: $15.47M
  • BHVN BIOHAVEN LTD · prev qtr: $6.50M

Insider Transactions (Form 4)

Latest BOONE CAPITAL MANAGEMENT LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Boone Capital Management is an SEC-registered 13F filer based in Atlanta, GA, United States. As of Q3 2026 it reported 16 US equity positions with a combined value of $376.70M. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).

Firm Snapshot

  • Headquarters: ATLANTA, GA, United States
  • SEC registration: 801-126199 (status: Approved), registered 2022-07-27
  • Regulatory AUM (Form ADV): $963.17M as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 16 positions · $376.70M reported value (Q3 2026)
  • Top 10 holdings = 81.1% of reported value
  • Largest position: BMRN (BIOMARIN PHARMACEUTICAL INC) at 10.7%
  • Average position size: $23.54M

Sector Tilt

  • Health Care 75.8%
  • Consumer Staples 7.8%
  • Industrials 7.3%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q3 2026: 5 new, 3 added, 5 reduced, 5 exited
  • 3 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.5%
Financials 9.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 428.79K $37.38M 16.03%
16.03%
Add
2 641.45K $32.64M 14.00%
14.00%
Add
3 447.45K $24.60M 10.55%
10.55%
Add
4 1.69M $22.81M 9.78%
9.78%
New
5 281.79K $22.76M 9.76%
9.76%
Reduce
6 180.34K $22.67M 9.72%
9.72%
New
7 649.02K $19.37M 8.31%
8.31%
Reduce
8 58.11K $18.13M 7.78%
7.78%
New
9 95.83K $13.94M 5.98%
5.98%
New
10 35.60K $11.77M 5.05%
5.05%
Reduce
11 1.25M $7.13M 3.06%
3.06%
New

FAQ

What did BOONE CAPITAL MANAGEMENT LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, BOONE CAPITAL MANAGEMENT LLC reported 11 equity positions worth $233.19M in aggregate; its largest disclosed positions were MDT ($37.38M), MIRM ($32.64M), BMRN ($24.60M).

How large is BOONE CAPITAL MANAGEMENT LLC's portfolio?

BOONE CAPITAL MANAGEMENT LLC reported $233.19M of long equity holdings across 11 positions as of 2025-Q2. Top-10 holdings account for 96.9% of reported value.

What is BOONE CAPITAL MANAGEMENT LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/boone-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →